Systems biology in reproductive medicine
About this article Cite this article Akano, O.P., Olatinwo, G., Hamed, M.A
Coverage policies vary widely: a KFF 2025 employer survey found 43% of firms with 5,000+ workers now cover GLP-1 weight-loss drugs (up from 28% in 2024) ( [6] ), yet many patient advocacy reports and journalists note patients cutting doses or resorting to unapproved sources due to cost ( [4] ) ( [7] )
Physicians seem to be clamoring for drugs with fewer side effects, Peter Bak, partner and managing director of Back Bay Life Science Advisors, told BioSpace last month
Handle according to laboratory safety protocols and institutional research guidelines
Over time, this can increase the risk of losing valuable lean muscle mass alongside body fat